CoChat

Rationale for hypoxia assessment and amelioration for precision therapy and immunotherapy studies

Open access
Dewhirst, Mark W., Mowery, Yvonne M., Mitchell, James B., Cherukuri, Murali K., Secomb, Timothy W. · 2019 · Journal of Clinical Investigation
Cited by 41

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

. Precision oncology has emerged as a major focus of cancer therapeutics. This strategy is based on the hope that therapy tailored to the specific molecular features of a patient’s cancer will yield superior results, compared with the traditional “one-size-fits-all” therapeutic approach (1). Similarly, modern immunotherapeutic approaches aim to take advantage of establishing a tumor-specific immune response that will eradicate tumor cells within an individual patient and provide lasting antitumor immune memory (2). Despite promising advances in precision oncology, hypoxia (defined here as partial pressure of oxygen [pO2] <10 mmHg) remains a significant barrier to therapeutic efficacy. Small molecule–targeted agents are susceptible to cellular drug resistance mechanisms, including mechanisms driven by hypoxia (3, 4). Spatial and temporal variation in tumor hypoxia (5) may contribute to the heterogeneity in treatment response to precision oncology drug combinations (1). Hypoxia influences efficacy of immunotherapy via several mechanisms, including both innate and adaptive immunity. For example, hypoxia promotes polarization of macrophages toward the immunosuppressive M2 phenotype (6) and affects NK cell function by reducing expression of the activating receptor NKG2D (7). With respect to the adaptive immune system, hypoxia disturbs the balance between effector T cells and immunosuppressive regulatory T cells (8). Hypoxia also interferes with immune checkpoint balance by decreasing MHC class I expression by tumor cells (9), increasing programmed death ligand 1 (PD-L1) […]

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci126044

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 41

Metadata

Authors
Dewhirst, M. W., Mowery, Y. M., Mitchell, J. B., Cherukuri, M. K., & Secomb, T. W.
Venue
Journal of Clinical Investigation
Published
2019-01-07
Volume
129
Issue
2
Pages
489-491
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2908226469
Cited by
41
References
9
FWCI
1.87
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rationale for hypoxia assessment and amelioration for precision therapy and immunotherapy studies. https://app.cochat.ai/papers/10.1172/jci126044
The paper
Dewhirst, M. W., Mowery, Y. M., Mitchell, J. B., Cherukuri, M. K., & Secomb, T. W. (2019). Rationale for hypoxia assessment and amelioration for precision therapy and immunotherapy studies. Journal of Clinical Investigation. https://doi.org/10.1172/jci126044

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.